Health / Medical Topics

    Hu14.18-IL2 Fusion Protein

    Definition 1

    A recombinant protein consisting of the hu14.18 monoclonal antibody fused to the cytokine interleukin-2 (IL2) with potential antineoplastic activity. The monoclonal antibody portion of the hu14.18-IL2 fusion protein binds to tumor cells expressing the GD2 antigen (melanoma, neuroblastoma and certain other tumors); the Fc component of the fusion protein antibody moiety and natural killer (NK) cells mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cellular cytotoxicity (CDCC) towards GD2-expressing tumor cells. The localized IL2 moiety of the fusion protein stimulates NK and T-cell antitumor cellular immune responses. (NCI Thesaurus)

    Definition 2

    An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells. (NCI Dictionary)




    YOU MAY ALSO LIKE

    A DNA-binding and thermostable low-molecular-weight E. coli protein that resembles eukaryotic histones. Acts as a cofactor in transcriptional repression. (from IRB…
    Human HTT wild-type allele is located in the vicinity of 4p16.3 and is approximately 199 kb in length. This allele, which encodes…
    This gene may be involved in vesicle transport.
    Human HTRA1 wild-type allele is located in the vicinity of 10q26.3 and is approximately 53 kb in length. This allele, which encodes…
    This gene plays a role in proteolysis.
    Definition: Human HTR3A wild-type allele is located in the vicinity of 11q23.1 and is approximately 15 kb in length. This allele, which…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact